Spinal hemangiopericytomas are rare tumors. To date, only 80 cases of spinal hemangiopericytomas have been reported in the literature. The postoperative evolution of this condition in rare cases can be complicated by a symptomatic compressive epidural hematoma that can be the source of serious neurological complications requiring emergency surgery. We report a rare case of intradural and extramedullary spinal hemangiopericytomas with favorable evolution after treatment in an 82 years old woman.
Introduction
The hemangiopericytoma is a rare and malignant tumor of the central nervous system classically developed from the meninges and able to metastasize outside the neuraxis [1] . It represents less than 1% of all the central nervous system tumors and 2% of the primary meningeal tumors [2] . Hemangiopericytomas have been first considered to be angioblastic meningiomas before OMS classified them as non-meningothelial tumors of mesenchymal origin in 1993 [1] . Since the 2016 central nervous tumors classification of the WHO, they are grouped with solitary fibrous tumors (TFS) under the same entity: TFS/hemangiopericytoma [3] . Most primary hemangiopericytomas of the central nervous system are intracranial and rarely located in the spine. The secondary spinal location is most often related to an intracranial origin [4] . The diagnosis is histologic and mole-Open Journal of Modern Neurosurgery cular [2] . The complete surgical resection remains the standard treatment and the interest of radiotherapy remains controversial [5] . The outcome in case of an incomplete surgical resection is generally marked by a high rate of the tumor relapse in the local site [6] . To date, only about 80 cases of spinal hemangiopericytomas have been reported in the literature [1] . We report a rare case of an intradural and extra-medullary thoracic hemangiopericytoma.
Case Report
An 82-year-old patient was hospitalized for a motor deficit of the lower right limb that was disturbing her gait and evolving for three weeks. A functional reeducation prescription has been made and is still going on. A brain MRI performed in order to the research for a primary tumor site was negative. A complementary radiotherapy, more precisely a volumetric arc therapy with intensity modulation has been carried out. It has consisted of a 52 grays administered in 26 fractions. At the postoperative consultation five months after the surgery the patient had an improvement in motor strength. This one was rate at 3/5. The research for distant metastatic foci after radiotherapy was negative.
Discussion
Hemangiopericytomas are rare vascular and aggressive tumors developed at the expense of Zimmermann's pericytes [1] [7] . The 2016 WHO classification considers hemangiopericytomas and solitary fibrotic tumors of the nervous system as the same pathological entity due to immunohistochemical and molecular lesional similarities [3] . The primary spinal location of hemangiopericytomas has been rarely reported in the literature [2] . To date, about 80 cases of spinal hemangiopericytomas have been reported and the cervico-dorsal spine is the most frequent site [1] . The clinical manifestation can be summarized as a motor deficit, radiculalgia and sensory disorders [1] . The sphincter disorders are relatively rare and late [8] . The case we report was clinically manifested only by a deficit in the right lower limb. The radiological figures of spinal hemangiopericytomas are nonspecific and have similarities with other spinal tumors, including meningiomas and neuromas [5] . The tumor, most often, has an intradural, extramedullary localization, well circumscribed with a dural attachment [1] . Purely intramedullary or purely intradural locations are rare [8] . The tumor is most often heterogeneously enhanced on MRI in T1 sequence with injection of gadolinium [9] . The presence of voids signals zones in T2 sequence is indicative of the hypervascularized nature of the tumor [5] . The case we report had rather a homogeneous enhancement with T1 contrast MRI and no T2 void signal. The have been successful for intracranial hemangiopericytomas [7] . Thus, surgery is the first-line treatment of spinal hemangiopericytomas [8] . Complete resection of the tumor is the main objective. The extent of tumor resection correlates with a low rate of long-term tumor recurrence [10] . However, the vascular nature of the tumor may be responsible for significant intraoperative bleeding thus making complete excision difficult. This haemorrhagic risk is thought to be responsible for high mortality and morbidity. Preoperative tumor endovascular embolization has been shown to be effective in reducing bleeding during the surgery and facilitating tumor resection [11] . In our case, the tumor could not be resected completely because of the capsular residue adhering to the spinal cord.
The high risk of recurrence of spinal hemangiopericytomas, especially in cases of incomplete resection and high grade tumor, which was the case for our patient, justifies the use of adjuvant radiotherapy [12] . Adjuvant radiotherapy would promote local control of the tumor [1] . For some authors, the combination of complete tumor resection with radiotherapy would significantly increase the time of tumor recurrence compared to exclusive tumor resection for high-grade tumors (213 months versus 43 months) [13] . Exclusive radiotherapy would be useful in case of nonoperable or small tumor [12] . Chemotherapy alone has not yet been shown to be effective in the treatment of spinal hemangiopericytomas [12] . But anti-angiogenic molecules could produce better results and are still under study [5] . The recurrence time for hemangiopericytomas in general is between 2 and 18 years on average, warranting a close monitoring, especially during the first five years after surgery [5] . Spinal Hemangiopericytomas are rare tumors which are usually difficult to be totally removed.
The relapse of the tumors locally or metastases appearance is very common regarding the outcome of this disease. A close post-operative monitoring could be useful to detect such complications. 
Conclusion
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